Datasets:
patient_id string | study_date string | num_slices int32 | tumor_slice_idx int32 | tumor_voxels_upenn int64 | has_cwru_mask bool | T1 image | T1c image | T2 image | FLAIR image | seg_UPenn image | overlay_UPenn image | seg_CWRU image | overlay_CWRU image | age string | gender string | histopathology string | location string | extent_of_resection string | survival_days string | molecular_subtype string | idh1 string | mgmt string | egfr string | included_upenn string | included_cwru string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
W1 | 1996.10.25 | 155 | 90 | 150,203 | true | 66 | Male | GBM; Gr.IV; GBM; Gr.IV | Right Frontal | Complete | 105.0 | Classical | wildtype | 40% | amplification | Yes | Yes | ||||||||
W2 | 1996.11.01 | 155 | 101 | 111,614 | true | 64 | Female | GBM; Gr.IV | Right Frontal | Complete | 1096.0 | Classical; Neural | wildtype | negative | amplification | Yes | Yes | ||||||||
W4 | 1996.12.01 | 155 | 102 | 98,512 | true | 50 | Female | GBM Gr.IV; GBM Gr.IV | Right Frontal | Complete | 540.0 | Mesenchymal; Neural | wildtype | 80% | gain | Yes | Yes | ||||||||
W5 | 1996.12.11 | 155 | 88 | 147,861 | true | 64 | Female | GBM; Gr.IV | Right Frontal | Complete | Classical; Neural | wildtype | 20% | amplification | Yes | Yes | |||||||||
W6 | 1996.11.28 | 155 | 86 | 46,230 | false | 72 | Female | GBM Gr.IV | Left Occipital | Complete | 633.0 | Mesenchymal | wildtype | 90% | gain | Yes | No | ||||||||
W7 | 1996.12.18 | 155 | 69 | 126,642 | true | 60 | Male | GBM Gr.IV | Right Temporal | Sub-total | 437.0 | Mesenchymal | wildtype | negative | gain | Yes | Yes | ||||||||
W8 | 1997.03.24 | 155 | 89 | 83,463 | true | 49 | Female | GBM; Gr.IV | Left Parietal | Complete | 442.0 | Classical; Mesenchymal | wildtype | 30% | gain | Yes | Yes | ||||||||
W9 | 1997.04.10 | 155 | 92 | 224,832 | true | 50 | Male | GBM | Right Frontal | Complete | 145.0 | Proneural | wildtype | 30% | gain | Yes | Yes | ||||||||
W10 | 1997.04.29 | 155 | 90 | 105,016 | true | 44 | Female | GBM; Gr.IV | Left Parietal | Complete | Proneural | R132H | negative | gain | Yes | Yes | |||||||||
W11 | 1997.05.11 | 155 | 84 | 111,967 | true | 57 | Male | GBM; Gr.IV | Right Parietal | Complete | 1076.0 | Classical; Mesenchymal | wildtype | 50% | gain | Yes | Yes | ||||||||
W12 | 1997.06.20 | 155 | 82 | 138,460 | true | 61 | Female | GBM; with small cell features; Gr.IV | Right Temporal | Sub-total | 80.0 | Classical | wildtype | 20% | amplification | Yes | Yes | ||||||||
W13 | 1997.08.22 | 155 | 84 | 147,383 | true | 59 | Female | GBM | Right Parietal | Complete | 250.0 | Mesenchymal | wildtype | 50% | amplification | Yes | Yes | ||||||||
W18 | 1997.11.10 | 155 | 93 | 77,740 | true | 36 | Female | GBM; giant cell type; Gr.IV | Right Parietal | Sub-total | 903.0 | wildtype | 25% | gain | Yes | Yes | |||||||||
W19 | 1997.11.14 | 155 | 53 | 12,470 | true | 67 | Female | GBM; Gr.IV | Left Temporal | Complete | 615.0 | Proneural | wildtype | 30% | gain | Yes | Yes | ||||||||
W20 | 1997.05.16 | 155 | 66 | 158,476 | true | 43 | Male | recurrent GBM | Right Parietal; Right Temporal | Complete | 363.0 | Mesenchymal | wildtype | 80% | gain | Yes | Yes | ||||||||
W22 | 1998.01.02 | 155 | 72 | 79,098 | true | 52 | Female | Edematous glioma; Anaplastic astro.; Gr.III / IV | Left Temporal | Complete | Classical; Neural; Neural | wildtype | 20% | amplification | Yes | Yes | |||||||||
W26 | 2000.07.12 | 155 | 93 | 95,788 | true | 57 | Female | GBM | Right Parietal; Right Temporal | Complete | 1293.0 | Neural | wildtype | Yes | Yes | ||||||||||
W29 | 1998.05.21 | 155 | 93 | 78,584 | true | 73 | Male | GBM | Right Parietal | Complete | 260.0 | Classical; Neural | wildtype | 10%-15% | amplification | Yes | Yes | ||||||||
W30 | 1998.06.08 | 155 | 97 | 85,112 | false | 59 | Male | GBM; Gr.IV | Left Parietal | Sub-total | 759.0 | wildtype | 15% | amplification | Yes | No | |||||||||
W32 | 1998.07.01 | 155 | 86 | 173,793 | true | 56 | Male | GBM; Gr.IV | Right Frontal | Complete | Proneural | wildtype | negative | gain | Yes | Yes | |||||||||
W33 | 1998.07.04 | 155 | 92 | 107,675 | true | 60 | Male | GBM; Gr.IV | Right Parietal | Complete | Classical | wildtype | 25% | amplification | Yes | Yes | |||||||||
W34 | 1998.07.13 | 155 | 70 | 98,996 | true | 73 | Male | GBM; Gr.IV | Left Temporal | Complete | 351.0 | Classical; Mesenchymal | wildtype | 50% | gain | Yes | Yes | ||||||||
W35 | 1998.07.11 | 155 | 95 | 51,790 | true | 36 | Female | Anaplastic astrocytoma Gr.III/IV | Right Parietal | Complete | R132H | 0% | gain | Yes | Yes | ||||||||||
W36 | 1998.07.14 | 155 | 50 | 46,538 | true | 61 | Male | GBM; Gr.IV | Left Parietal | Sub-total | 544.0 | Mesenchymal | wildtype | 70% | gain | Yes | Yes | ||||||||
W38 | 1998.09.10 | 155 | 68 | 170,299 | true | 64 | Female | GBM; Gr.IV/IV | Right Temporal | Sub-total | 311.0 | Proneural | wildtype | negative | gain | Yes | Yes | ||||||||
W39 | 1998.09.19 | 155 | 100 | 138,024 | true | 67 | Female | GBM | Right Frontal | Sub-total | 880.0 | Classical | wildtype | 25% | amplification | Yes | Yes | ||||||||
W40 | 1998.10.10 | 155 | 71 | 42,643 | true | 64 | Male | GBM | Left Parietal | Complete | 184.0 | Neural | wildtype | 40% | gain | Yes | Yes | ||||||||
W42 | 1999.03.30 | 155 | 83 | 59,365 | true | 59 | Female | GBM | Right Frontal; Right Temporal | Complete | 197.0 | Neural; Proneural | wildtype | Yes | Yes | ||||||||||
W43 | 1999.04.09 | 155 | 66 | 108,060 | true | 61 | Female | GBM | Right Temporal | Complete | 300.0 | Mesenchymal; Neural | wildtype | Yes | Yes | ||||||||||
W48 | 1999.10.21 | 155 | 83 | 84,845 | true | 51 | Male | GBM; GBM | Right Parietal | Complete | 456.0 | Neural | R132G | Yes | Yes | ||||||||||
W50 | 1999.12.15 | 155 | 93 | 78,549 | true | 26 | Male | GBM Gr.IV; Anaplastic astro. Gr.III | Left Parietal | Complete | wildtype | Yes | Yes | ||||||||||||
W53 | 2000.06.01 | 155 | 71 | 158,381 | true | 54 | Male | GBM Gr.IV | Left Temporal | Complete | Classical | wildtype | Yes | Yes | |||||||||||
W54 | 2000.09.02 | 155 | 82 | 120,394 | false | 57 | Male | GBM Gr.IV | Left Temporal | Complete | 62.0 | Proneural | wildtype | Yes | No | ||||||||||
W55 | 2000.10.31 | 155 | 55 | 98,011 | true | 52 | Male | GBM Gr.IV | Right Temporal | Complete | Classical | wildtype | Yes | Yes |
IvyGAP-Radiomics (SRI-atlas subset)
Multi-parametric brain-MRI glioblastoma (GBM) segmentation dataset: 4 co-registered, skull-stripped MRI sequences per subject with expert tumor sub-compartment masks from two independent institutions, plus precomputed radiomic features. From the TCIA Analysis Result collection IvyGAP-Radiomics (Pati et al., 2020).
⚠️ Scope — this is a preprocessed subset of the full Ivy GAP project
"IvyGAP-Radiomics" is not the complete Ivy Glioblastoma Atlas Project (Ivy GAP). It is a derived analysis result containing only the pre-operative scans, skull-stripped and co-registered to the SRI24 atlas, converted to NIfTI, with expert tumor masks and radiomic features added. It does not include the original DICOM imaging (~140 GB), histology (ISH), or gene-expression / genomic data of the parent Ivy GAP collection. Only the SRI-atlas package is mirrored here (the alternate MNI-atlas / CWRU-only package is not included).
🔴 Cross-dataset overlap with BraTS (evaluation-integrity hazard)
Pre-operative IvyGAP data is included in the BraTS challenge training set (together with
TCGA-GBM, TCGA-LGG, CPTAC-GBM), and these masks were produced with the BraTS preprocessing
pipeline (SRI24 atlas, skull-strip) and follow the BraTS labeling convention. Do not
benchmark these subjects against any BraTS-trained model, or alongside Angelou0516/brats2023-*,
without treating the results as non-held-out — there is likely train/test leakage. Subjects are
identified by Ivy GAP IDs (W1…W55); there is no published BraTS-ID cross-reference column,
so any mapping to BraTS subjects must be done externally via the Ivy GAP → BraTS name tables.
Two expert raters — no single gold standard (by design)
The dataset's purpose is inter-rater reproducibility. Each tumor was segmented independently by board-certified neuroradiologists at two institutions:
- UPenn (Hospital of the University of Pennsylvania) — 34 subjects
- CWRU (Case Western Reserve University) — 31 subjects
31 subjects are paired (annotated by both). The paper anoints neither rater as "the" ground truth — both are equally-valid expert annotations. Both mask sets are provided here. For a single-GT workflow, the recommended default is UPenn (broader coverage: 34 vs 31). Subjects without a CWRU mask: W6, W30, W54.
Labels (BraTS convention)
| value | sub-compartment |
|---|---|
| 0 | background |
| 1 | NCR/NET — necrotic & non-enhancing tumor core |
| 2 | ED — peritumoral edema / invaded tissue |
| 4 | ET — enhancing tumor |
Composite regions: TC (tumor core) = {1,4}; WT (whole tumor) = {1,2,4}; ET = {4}.
Mask dtypes as released: UPenn uint16, CWRU float32 — both encode the integer labels above
(content is preserved byte-for-byte; cast to integer when loading).
Geometry
All volumes are 240 × 240 × 155 @ 1.0 mm isotropic in SRI24 space, skull-stripped, LPS orientation. One pre-operative study per subject.
Structure
W{n}/ # one folder per subject, at the repo root
W{n}_t1.nii.gz # native T1
W{n}_t1c.nii.gz # post-contrast T1 (T1-Gd; original token "t1gd")
W{n}_t2.nii.gz # T2
W{n}_flair.nii.gz # T2-FLAIR
W{n}_seg-UPenn.nii.gz # UPenn expert mask (all 34 subjects)
W{n}_seg-CWRU.nii.gz # CWRU expert mask (31 subjects)
atlas/spgr_unstrip_lps.nii.gz # SRI24 reference template
data/test-*.parquet # Dataset Viewer preview only (rendered slices + metadata)
radiomic_features/ # CaPTk/IBSI features per rater, feature parameters, reproducibility correlations
ivygap_metadata.csv # per-subject clinical & molecular metadata (see below)
subject_study_dates.csv # subject -> original study date + which rater masks exist
ivygap_metadata.csv
Per-subject metadata keyed by Patient (W-ID). Columns include Included_Upenn,
Included_CWRU, 4_Modalities (inclusion flags), Age, gender, Histopathology,
location, EoR (extent of resection), Surgery, survival_days, Molecular_subtype,
IDH1, 1p19q_deletion, MGMT/MGMT PCR, EGFR/EGFR vIII, PTEN, KPS(initial),
time-to-progression / last-follow-up, and cause of death. (The CSV also lists a few subjects
that lack 4-modality imaging and are therefore not present under data/.)
Provenance, license & citation
- Provenance: Official TCIA Analysis Result (author-provided), DOI 10.7937/9j41-7d44. SRI-atlas package downloaded via TCIA IBM-Aspera faspex5.
- License: CC BY 3.0 (TCIA Analysis Results) + the TCIA Data Usage Policy.
- Data citation: Pati, S., Verma, R., Akbari, H., Bilello, M., Hill, V.B., Sako, C., Correa, R., Beig, N., Venet, L., Thakur, S., Serai, P., Ha, S.M., Blake, G.D., Shinohara, R.T., Tiwari, P., Bakas, S. (2020). Data from the Multi-Institutional Paired Expert Segmentations and Radiomic Features of the Ivy GAP Dataset. The Cancer Imaging Archive. DOI 10.7937/9j41-7d44.
- Publication: Pati S, et al. Reproducibility analysis of multi-institutional paired expert annotations and radiomic features of the Ivy GAP dataset. Medical Physics 2020;47(12):6039–6052. DOI 10.1002/mp.14556.
- Downloads last month
- 9